6 completed. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
Follow raltitrexed: new trials by email Literature Review of raltitrexed trials Research Report on raltitrexed
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Raltitrexed in HIPEC Raltitrexed - Colorectal Cancer, Raltitrexed | Phase 1 | Completed | Fudan University | 30 | 2020-09-18 | 2026-02-25 |
| Raltitrexed in Treating Children With Refractory Acute Leukemia raltitrexed - Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 1998-09-01 | 2013-01-16 |
| Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors irinotecan hydrochloride, raltitrexed - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Fox Chase Cancer Center | 39 | 1997-12-01 | 2013-04-17 |
| Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors irinotecan hydrochloride, raltitrexed - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Abramson Cancer Center at Penn Medicine | 1997-04-01 | 2019-03-13 | |
| Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer fluorouracil, raltitrexed - Colorectal Cancer | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 1995-04-01 | 2013-06-21 | |
| A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease ZD1694 (TOMUDEX) - Neoplasm | Phase 1 | Completed | National Cancer Institute (NCI) | 60 | 1993-09-01 | 2008-03-04 |
Colorectal Neoplasms (2) · Colonic Neoplasms (1) · Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Rectal Neoplasms (1)
National Cancer Institute (NCI) (2) · Abramson Cancer Center at Penn Medicine (1) · Fox Chase Cancer Center (1) · Fudan University (1) · Memorial Sloan Kettering Cancer Center (1)
United States (4) · China (1) · Switzerland (1)
Gary K. Schwartz, MD (1) · Neal J. Meropol, MD (1) · Peter J. O'Dwyer, MD, BCh (1) · Steven D. Weitman (1)
P30CA006927 (1), U01CA097452 (1)